Stock data
MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics, Inc. (INKT) reported net income of -US$12.49M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$12.64M | -US$12.49M | — |
| 2024 | — | — | -US$11.29M | -US$10.78M | — |
| 2023 | — | — | -US$22.92M | -US$22.46M | — |
| 2022 | — | — | -US$30.95M | -US$27.99M | — |
| 2021 | — | — | -US$28.36M | -US$30.21M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.13M | — |
| 2026-03-31 | — | -US$2.74M | — |
| 2025-12-31 | — | -US$2.60M | — |
| 2025-09-30 | — | -US$2.89M | — |
| 2025-06-30 | — | -US$4.24M | — |
| 2025-03-31 | — | -US$2.77M | — |
| 2024-12-31 | — | -US$2.46M | — |
| 2024-09-30 | — | -US$1.81M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.